The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Intervention combining nurse navigators (NNs) and a mobile application versus standard of care (SOC) in cancer patients (pts) treated with oral anticancer agents (OAA): Results of CapRI, a single-center, randomized phase III trial.
 
Olivier Mir
Stock and Other Ownership Interests - Amplitude Surgical; Ipsen; Transgene
Honoraria - Roche
Consulting or Advisory Role - Janssen; Lilly; Lundbeck; Pfizer; Roche
Speakers' Bureau - Lilly; Pfizer; Roche
Travel, Accommodations, Expenses - Pfizer; Roche
 
Marie Ferrua
Consulting or Advisory Role - Novartis
 
Aude Fourcade
No Relationships to Disclose
 
Delphine Mathivon
No Relationships to Disclose
 
Adeline Duflot-Boukobza
No Relationships to Disclose
 
Sarah Naomie Dumont
No Relationships to Disclose
 
Eric Baudin
No Relationships to Disclose
 
Suzette Delaloge
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
David Malka
Honoraria - Amgen; Bayer; HalioDx; Merck Serono; Pierre Fabre; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Amgen; Baxalta; Bayer; HalioDx; Incyte; Merck Serono; MSD; Roche; Sanofi; SERVIER
Travel, Accommodations, Expenses - Amgen; Bayer; Merck Serono; Roche; Sanofi
 
Laurence Albiges
Consulting or Advisory Role - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Exelixis (Inst); Ipsen (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Novartis (Inst); Peloton therapeutics (Inst); Pfizer (Inst); Roche (Inst)
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Patricia Pautier
No Relationships to Disclose
 
Caroline Robert
Consulting or Advisory Role - Amgen; Biothera; Bristol-Myers Squibb; CureVac; Merck; MSD; Novartis; Pierre Fabre; Roche; Sanofi
 
David Planchard
Honoraria - PeerVoice; Prime Oncology
Consulting or Advisory Role - AstraZeneca; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; MedImmune; MSD Oncology; Novartis; Pfizer; Roche
Research Funding - Abbvie (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi/Aventis (Inst); Taiho Pharmaceutical (Inst)
 
Stéphane de Botton
No Relationships to Disclose
 
François Lemare
Employment - AstraZeneca; SERVIER (I)
Honoraria - Pfizer
Consulting or Advisory Role - Biogaran Pharmaceuticals; MSD Oncology
 
Marilene Guillet
No Relationships to Disclose
 
Vanessa Puglisi
No Relationships to Disclose
 
May Abbas
No Relationships to Disclose
 
Mario Di Palma
No Relationships to Disclose
 
Etienne Minvielle
No Relationships to Disclose